Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Ryan Specialty Holdings Inc. (RYAN) Stock Forecast & Price Prediction United States | NYSE | Financial Services | Insurance - Specialty
$41.29
-0.29 (-0.70%)Did RYAN Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Ryan Specialty is one of their latest high-conviction picks.
Based on our analysis of 5 Wall Street analysts, RYAN has a bullish consensus with a median price target of $40.00 (ranging from $31.00 to $76.00). The overall analyst rating is Buy (7.6/10). Currently trading at $41.29, the median forecast implies a -3.1% downside. This outlook is supported by 10 Buy, 8 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for RYAN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 7, 2026 | Barclays | Alex Scott | Overweight | Maintains | $46.00 |
| Jul 6, 2026 | Morgan Stanley | Bob Huang | Overweight | Maintains | $42.00 |
| Jul 1, 2026 | Goldman Sachs | Robert Cox | Neutral | Maintains | $40.00 |
| Jun 9, 2026 | UBS | Buy | Maintains | $N/A | |
| Jun 8, 2026 | Goldman Sachs | Neutral | Downgrade | $N/A | |
| May 21, 2026 | Morgan Stanley | Overweight | Maintains | $N/A | |
| May 4, 2026 | UBS | Buy | Maintains | $N/A | |
| May 4, 2026 | Citigroup | Buy | Maintains | $N/A | |
| May 1, 2026 | Piper Sandler | Neutral | Maintains | $N/A | |
| May 1, 2026 | Barclays | Overweight | Maintains | $N/A | |
| May 1, 2026 | Keefe, Bruyette & Woods | Outperform | Maintains | $N/A | |
| May 1, 2026 | Wells Fargo | Equal-Weight | Downgrade | $N/A | |
| Apr 14, 2026 | B of A Securities | Buy | Maintains | $N/A | |
| Apr 13, 2026 | Mizuho | Neutral | Maintains | $N/A | |
| Apr 9, 2026 | JP Morgan | Underweight | Maintains | $N/A | |
| Apr 9, 2026 | Wells Fargo | Overweight | Maintains | $N/A | |
| Apr 9, 2026 | Cantor Fitzgerald | Neutral | Maintains | $N/A | |
| Apr 8, 2026 | UBS | Buy | Maintains | $N/A | |
| Apr 8, 2026 | Barclays | Overweight | Maintains | $N/A | |
| Apr 8, 2026 | Goldman Sachs | Buy | Maintains | $N/A |
The following stocks are similar to Ryan Specialty based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Ryan Specialty Holdings Inc. has a market capitalization of $10.72B with a P/E ratio of 50.1x. The company generates $3.10B in trailing twelve-month revenue with a 3.5% profit margin.
Revenue growth is +15.8% quarter-over-quarter, while maintaining an operating margin of +17.4% and return on equity of +22.8%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides specialty insurance solutions for various sectors.
The company operates in the wholesale brokerage and underwriting space, generating revenue by offering specialized insurance products and risk management solutions that address unique needs in the commercial insurance market. It caters to brokers, agents, and direct consumers across multiple industries, ensuring tailored coverage for complex risks.
Ryan Specialty Holdings is headquartered in Chicago, Illinois, and has a strong presence in both U.S. and international markets. The company is recognized for its innovative approach to risk management, helping clients navigate emerging risks that traditional insurance markets often overlook.
Financial Services
Insurance - Specialty
6,144
Mr. Timothy William Turner
United States
2021
Ryan Specialty Underwriting Managers has completed a series of Lloyd's of London consortium stamps, securing a 15% share for its global P&C delegated underwriting portfolio, supported by six syndicates.
The completion of Lloyd's consortium stamps enhances RSUM's underwriting capacity and diversification, potentially leading to increased revenue and competitiveness in the P&C market.
Ryan Specialty Holdings, Inc. (NYSE: RYAN) will release Q2 2026 financial results on July 30, 2026, after market close, followed by a conference call at 4:45 PM ET.
Ryan Specialty's upcoming financial results release and conference call could signal performance trends, impacting stock valuation and investor sentiment in the specialty insurance sector.
Director Anthony Kuczinski purchased 3,000 shares at ~$34.99 each, totaling ~$105,000, increasing his ownership by 29.79% to 13,072 shares.
Director Anthony Kuczinski's purchase signals confidence in the company's future, potentially boosting investor sentiment and stock value. Increased ownership may indicate a positive outlook.
RT Specialty plans a leadership succession effective August 1, 2026. CEO Ed McCormack will become Vice Chairman, indicating a strategic transition in management.
Leadership succession at RT Specialty signals stability and continuity, which can positively impact investor confidence and potentially influence stock performance for Ryan Specialty.
The Schall Law Firm is investigating Ryan Specialty Holdings, Inc. (NYSE: RYAN) for potential securities law violations, including false statements and failure to disclose key information to investors.
The investigation into Ryan Specialty Holdings may indicate potential legal issues and financial risks, affecting the stock's credibility and performance, which could impact investor decisions.
Ryan Specialty Holdings, Inc. (RYAN) presented at the 46th Annual William Blair Growth Stock Conference, sharing insights relevant to investors.
Ryan Specialty Holdings' presentation at a major conference signals potential growth insights and strategic direction, influencing investor sentiment and stock performance.
Based on our analysis of 5 Wall Street analysts, Ryan Specialty Holdings Inc. (RYAN) has a median price target of $40.00. The highest price target is $76.00 and the lowest is $31.00.
According to current analyst ratings, RYAN has 10 Buy ratings, 8 Hold ratings, and 1 Sell ratings. The stock is currently trading at $41.29. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict RYAN stock could reach $40.00 in the next 12 months. This represents a -3.1% decrease from the current price of $41.29. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates in the wholesale brokerage and underwriting space, generating revenue by offering specialized insurance products and risk management solutions that address unique needs in the commercial insurance market. It caters to brokers, agents, and direct consumers across multiple industries, ensuring tailored coverage for complex risks.
The highest price target for RYAN is $76.00 from at , which represents a 84.1% increase from the current price of $41.29.
The lowest price target for RYAN is $31.00 from at , which represents a -24.9% decrease from the current price of $41.29.
The overall analyst consensus for RYAN is bullish. Out of 5 Wall Street analysts, 10 rate it as Buy, 8 as Hold, and 1 as Sell, with a median price target of $40.00.
Stock price projections, including those for Ryan Specialty Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.